Clinical Trials Logo

Sleep Disturbance clinical trials

View clinical trials related to Sleep Disturbance.

Filter by:

NCT ID: NCT03899727 Completed - Sleep Disturbance Clinical Trials

Sleep Disturbance in Pregnant Women in Upper Egypt

Start date: June 1, 2019
Phase:
Study type: Observational

Pregnant women are associated with hormonal, anatomic and mechanical changes that Change sleep patterns and quality of sleep. Several Investigators have reported Associations between sleep disturbances and hypertension, Coronary artery disease, Diabetes, and depression. Most of these associations have been established in the association with sleep disturbances

NCT ID: NCT03837249 Completed - Sleep Disturbance Clinical Trials

Self-Management of Sleep Among Older Adults

Start date: February 4, 2019
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to test the feasibility of older persons use of a personal sleep monitoring device(PSMD)to improve self-management of sleep. Disrupted sleep occurs in up to 50% of persons over the age of 65 with chronic health conditions. Impaired sleep negatively influences subjective and objective health outcomes.To improve their sleep, older adults with chronic health conditions could benefit from objective information, available through personal health monitoring devices, about their current and changing sleep patterns. Based on this information, sleep self-management interventions can be individualized and shared, and associations between sleep and health changes may be better managed.

NCT ID: NCT03796338 Completed - Critical Illness Clinical Trials

Sleep Quantity and Quality in the ICU: a Prospective Observational Stud

Start date: February 1, 2018
Phase:
Study type: Observational

Several evidences in the literature suggest sleep interruption in critical care patients. Nowadays, the amount and the quality of sleep phases during the length of stay in the intensive care unit are largely unknown. In this study, the amount of time spent by the patients in N1, N2 N3 and REM phases during sleep is quantified.

NCT ID: NCT03789214 Completed - Sleep Disturbance Clinical Trials

Medical Management of Sleep Disturbance During Opioid Tapering

Start date: July 1, 2019
Phase: Phase 2
Study type: Interventional

This study will evaluate whether a dual orexin-receptor antagonist approved by the FDA for sleep disturbance, suvorexant (SUVO; Belsomra), will increase total sleep time in patients with opioid use disorder (OUD) undergoing supervised withdrawal. This study is designed as a dose-finding study of SUVO compared to placebo. Briefly, OUD patients seeking supervised withdrawal will be admitted into a clinical research unit and stabilized onto buprenorphine for three days before being randomly assigned to study condition. All participants will then undergo a routine four-day buprenorphine taper, followed by a four-day post-taper phase. Participants will be randomized to receive either placebo, Low Dose SUVO, or High Dose SUVO and the investigators hypothesize that one or both doses of SUVO will improve total sleep time relative to placebo. Patients will attend a single follow-up session, 5-10 days following discharge.

NCT ID: NCT03779243 Completed - Trauma Clinical Trials

Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

Start date: January 7, 2019
Phase: N/A
Study type: Interventional

The purpose of the study is to test the efficacy of sleep treatment in human patients following traumatic injury. Specifically, the study will determine if treatment consisting of melatonin and education related to sleep habits are effective in treating sleep disturbance and improving sleep quality in Orthopaedic trauma patients. We hope to learn if melatonin and sleep education effectively improve sleep following traumatic injury, and improve outcomes.

NCT ID: NCT03763071 Completed - Pregnancy Clinical Trials

Sleep Disturbances in the 2nd and 3rd Trimester

Start date: December 7, 2018
Phase:
Study type: Observational

Sleep disorders and disturbances are mostly underestimated in clinical practice. Moreover, this problem is generally neglected by the pregnant themselves. Today, it is important to underline any problem that may have an affect to improve the quality of life during pregnancy. This study assesses the sleep quality, insomnia patterns and obstructive sleep apnea in the second and third trimesters of pregnancy.

NCT ID: NCT03730194 Completed - Clinical trials for Autism Spectrum Disorder

A SMART Design to Improve Sleep Disturbance in Adolescents With Neurodevelopmental Disorders

Start date: May 31, 2019
Phase: N/A
Study type: Interventional

The objective of this K01 study was to pilot a sequential, multiple assignment, randomized trial (SMART) design to compare the impact of a sequence of sleep interventions, based on participant treatment response, to optimize sleep health in adolescents 10-18 years of age with neurodevelopmental disorders (NDDs).

NCT ID: NCT03684057 Completed - Anxiety Clinical Trials

Targeting Worry to Improve Sleep

Start date: July 25, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to test an app-based mindfulness training program for worry to see if it can help individuals decrease worry and improve sleep.

NCT ID: NCT03673397 Completed - Depression Clinical Trials

The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression

EASED
Start date: September 24, 2018
Phase: N/A
Study type: Interventional

The aim of this trial is to investigate the effects of a single bout of aerobic exercise on sleep in patients with depression.

NCT ID: NCT03659630 Completed - Clinical trials for Stress, Psychological

MyCompass in a Swedish Context - an Automated Self-help Intervention Targeting Mental Health Problems

Start date: December 2015
Phase: N/A
Study type: Interventional

The study present findings from the implementation of myCompass, a fully automated self-help intervention of Australian origin for mild to moderate anxiety and depression, in a Swedish context. The study also investigates the usage of a specially designed research platform aimed at handling informed consent and online surveys.